Last reviewed · How we verify
NCT06890663
Telehealth-Delivered Gut-Directed Hypnotherapy for Managing GI Health
NA trial testing Nonspecific Hypnotherapy for Relaxation in Gastrointestinal Disease in 11 participants. Completed in 30 October 2025.
30 October 2025
Quick facts
| Lead sponsor | University of Central Florida |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 11 |
| Start date | 19 March 2025 |
| Primary completion | 30 October 2025 |
| Estimated completion | 30 October 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Nonspecific Hypnotherapy for Relaxation
- Gut-Directed Hypnotherapy (GDH)
- 3-month Follow-Up
Conditions studied
- Gastrointestinal Disease — all drugs for Gastrointestinal Disease →
- Gastrointestinal Disorders — all drugs for Gastrointestinal Disorders →
- Nervous System — all drugs for Nervous System →
Sponsor
University of Central Florida
Who can join
18 and older, any sex, with Gastrointestinal Disease or Gastrointestinal Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the specific and non-specific effects of hypnotherapy and to evaluate the efficacy of group-format gut-directed hypnotherapy (GDH) delivered via telehealth for managing gastrointestinal health.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06890663
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gastrointestinal Disease
Currently open trials in the same condition.
- NCT05053191 — Advancing Nursing Practices in Hospital Oncology Care · NA · active not recruiting
- NCT04949282 — Spanish Series of Patients Treated With the Radionuclide Lutetium177 · recruiting
- NCT03566160 — Pilot Study for Evaluation of Cryobiopsy and Correlation With Standard Forceps Biopsy · NA · active not recruiting
Other University of Central Florida trials
Trials by the same sponsor.
- NCT07203430 — Biopsychosocial Factors and Muscle Morphology After a Resistance Exercise · NA · completed
- NCT07214883 — UCF MammoChat: Image Repository · recruiting
- NCT06999057 — Quadriceps Motor Unit Adaptation to Simulated Knee Injury · NA · not yet recruiting
- NCT06979713 — Yoga, Education, and Nidra (YEN) for Chronic Low Back Pain: A Pilot Study on Pain Modulation, Well-Being, and Sleep · NA · not yet recruiting
- NCT06512168 — Measuring Aided Language Development · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06890663 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Central Florida
- Last refreshed: 4 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06890663.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing